Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Danuta Lis"'
Autor:
Zaynab Umakhanova, Paul A. De Sousa, Michaela Winkelmann, Rob Haselberg, Astri Arnesen, Marina Tretyakova, Danuta Lis, Beatrice De Schepper, Vladimír Václavík, Hans Gommans, Filipa Júlio, Emilie Hermant, Marios Papantoniou, Svein Olaf Olsen, Josè Perez Casanova, Cristina Ferreira, Ferdinando Squitieri, Ruth Blanco, Barbara D’Alessio, Sabrina Maffi, Dina De Sousa
Publikováno v:
F: Clinical studies: case reports, observational studies and trials.
Background The development of effective therapies for Huntington’s disease (HD) requires an active, informed, and lasting commitment from HD families to research. Specifically, those traditionally less involved in studies should be heard and engage
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::36dc9885d09b8025453e84e38af537f0
https://doi.org/10.1136/jnnp-2021-ehdn.55
https://doi.org/10.1136/jnnp-2021-ehdn.55
Autor:
Filipa Júlio, Ruth Blanco, Josè Perez Casanova, Barbara D’Alessio, Beatrice De Schepper, Dina De Sousa, Paul De Sousa, Cristina Ferreira, Hans Gommans, Rob Haselberg, Emilie Hermant, Danuta Lis, Sabrina Maffi, Svein Olaf Olsen, Marios Papantoniou, Ferdinando Squitieri, Marina Tretyakova, Zaynab Umakhanova, Vladimír Václavík, Michaela Winkelmann, Astri Arnesen, on behalf of the European Huntington Association
Publikováno v:
Journal of Personalized Medicine, Vol 11, Iss 815, p 815 (2021)
Journal of Personalized Medicine
Volume 11
Issue 8
Journal of Personalized Medicine
Volume 11
Issue 8
There has been great progress in Huntington’s disease (HD) research. Yet, effective treatments to halt disease before the onset of disabling symptoms are still unavailable. Scientific breakthroughs require an active and lasting commitment from fami
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcb77e5794ecdbd22a5b7aaa13f530a7
https://www.mdpi.com/2075-4426/11/8/815
https://www.mdpi.com/2075-4426/11/8/815
Autor:
Maria Roszkowska-Blaim, Barbara Gałazka, Jedrzejowski A, Małgorzata Pańczyk-Tomaszewska, Paweł Dyras, Danuta Lis
Publikováno v:
Pediatric nephrology (Berlin, Germany). 17(10)
The aim of the study was to assess the effect of recombinant human growth hormone (rhGH) on serum lipids in children treated with chronic peritoneal dialysis. We studied 26 patients aged 5-18 years, including 13 patients treated with rhGH at a dose o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e622215642806091cdc4939da30fb19
https://pubmed.ncbi.nlm.nih.gov/12376812
https://pubmed.ncbi.nlm.nih.gov/12376812
Minocycline for negative symptoms of schizophrenia and possible mechanistic actions: the BeneMin RCT
Autor:
Bill Deakin, John Suckling, Paola Dazzan, Eileen Joyce, Stephen M Lawrie, Rachel Upthegrove, Nusrat Husain, Imran B Chaudhry, Graham Dunn, Peter B Jones, Danuta Lisiecka-Ford, Shôn Lewis, Thomas RE Barnes, Steven CR Williams, Carmine M Pariante, Emma Knox, Richard J Drake, Richard Smallman, Nicholas M Barnes
Publikováno v:
Efficacy and Mechanism Evaluation, Vol 6, Iss 7 (2019)
Background: In a previous trial we reported that the neuroprotective, anti-inflammatory antibiotic minocycline lessened the negative symptoms of schizophrenia compared with placebo over 1 year. The BeneMin study aimed to replicate this benefit and to
Externí odkaz:
https://doaj.org/article/0626a27c0f1a4871b10da8417d20fe55